Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin).
暂无分享,去创建一个
[1] R. Agarwal,et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells , 2003, Oncogene.
[2] P. Dolara,et al. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. , 2003, Cancer research.
[3] Takuji Tanaka,et al. Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane‐induced colon carcinogenesis in male F344 rats , 2002, International journal of cancer.
[4] V. Steele,et al. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents. , 2002, Carcinogenesis.
[5] A. Hara,et al. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker. , 2002, European Journal of Cancer Prevention.
[6] A. Nishikawa,et al. Spontaneous development of aberrant crypt foci in F344 rats. , 2002, Journal of experimental & clinical cancer research : CR.
[7] D. Salvadori,et al. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[8] Wei Li,et al. Inhibition by ginseng of colon carcinogenesis in rats. , 2001, Journal of Korean medical science.
[9] R. Dashwood,et al. Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2‐amino‐3‐methylimidazo[4,5‐f]quinoline and treated post‐initiation with chlorophyllin , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[10] S. Skinner,et al. Non‐steroidal anti‐inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model 1 , 2000, Journal of gastroenterology and hepatology.
[11] V. Steele,et al. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. , 2000, Carcinogenesis.
[12] H. Daniel,et al. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. , 2000, Cancer research.
[13] T. Sugimura,et al. Suppression by Flavonoids of Cyclooxygenase‐2 Promoter‐dependent Transcriptional Activity in Colon Cancer Cells: Structure‐Activity Relationship , 2000, Japanese journal of cancer research : Gann.
[14] M. Bertagnolli,et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. , 2000, Carcinogenesis.
[15] V. Steele,et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. , 2000, The Journal of nutrition.
[16] S. Fukushima,et al. Inhibition by Ginseng of 1,2-Dimethylhydrazine Induction of Aberrant Crypt Foci in the Rat Colon , 2000, Nutrition and cancer.
[17] V. Steele,et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.
[18] J Ludbrook,et al. MULTIPLE COMPARISON PROCEDURES UPDATED , 1998, Clinical and experimental pharmacology & physiology.
[19] Tetsushi Watanabe,et al. Active oxygens generation by flavonoids. , 1998, Biological & pharmaceutical bulletin.
[20] V. Steele,et al. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[21] P. Hollman,et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.
[22] G. Kuttan,et al. Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.
[23] L. Roncucci,et al. Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy). , 1993, Cancer research.
[24] T. P. Pretlow,et al. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. , 1992, Carcinogenesis.
[25] D. Ahnen,et al. Regional variability of colonocyte growth and differentiation in the rat , 1992, The Anatomical record.
[26] A. Medline,et al. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. , 1991, Carcinogenesis.
[27] A. Jemal,et al. Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.
[28] S. Schwartz,et al. The identification of monoclonality in human aberrant crypt foci. , 1999, Cancer research.
[29] V. Steele,et al. Growth kinetics and chemoprevention of aberrant crypts in the rat colon , 1992, Journal of cellular biochemistry. Supplement.
[30] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.